From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Cripes it is almost 2024, can you hear the bubbling in the background?

By Tom Winnifrith | Thursday 2 November 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


That noise is two Christmas puddings which I am steaming. It being almost 2024 is relevant to shares as I discuss. I look at Genflow Biosciences (GENF) - target 0p - MGC Pharmaceuticals (MXC) - target 0p, Versarien (VRS) - target 0.1p first stop after a placing before Advent at that level, then 0p next year - Deepverge (DVRG) - target 0p - Global Petroleum (GBP) - target 0p - and Trainline(TRN) - target more than 0p but lower than today's 288p. 
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Ariana – Surprise!

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 18:33:42